Page last updated: 2024-08-23

buserelin and Menopause

buserelin has been researched along with Menopause in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199024 (52.17)18.7374
1990's22 (47.83)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Jong, FH; Klijn, JG1
Alexieva-Figusch, J; Blankenstein, MA; Blonk-van der Wijst, J; de Jong, FH; Docter, R; Klijn, JG; Lamberts, SW1
Jacobs, HS; Lightman, SL; Maguire, AK1
Aliaga, R; Cano, A1
Grunberg, SM1
Nakamura, Y; Yoshimura, Y1
Abu-Musa, A; Hannoun, A; Karam, K; Khalil, A; Masaad, Z1
Bianco, AR; Blamey, RW; Jonat, W; Kaufmann, M; Namer, M1
Coombes, RC; Dowsett, M; Stein, RC1
Aoki, Y; Honma, S; Kanazawa, K; Kodama, S; Kurabayashi, T; Tanaka, K; Yoshiya, N1
Barnes, JF; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Mack, A1
Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE1
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF1
Crosignani, PG; Maini, MC; Negri, E; Ragni, G1
Carpano, S; Di Lauro, L; Lopez, M; Veltri, E; Vici, P1
Blamey, RW; Bouzubar, N; Dixon, AR; Ellis, IO; McClelland, R; Nicholson, RI; Robertson, JF; Walker, KJ1
Bianco, AR; Calabresi, F; De Placido, S; Fiorentino, M; Fosser, V; Lenti, R; Lopez, M; Perrone, F; Rosso, R; Sismondi, PG1
Ando, M; Nakamura, Y; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y1
Abbate, R; Bruni, V; Cirri, R; Coppo, M; Pinto, S; Rosati, D1
Ito, M; Okamura, H; Sakoda, Y1
Ando, M; Maruyama, K; Nakamura, Y; Nanno, T; Suzuki, M; Takahashi, K; Ubukata, Y; Yamada, H; Yoshimura, Y1
Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R1
Bouzubar, N; Davies, P; Gee, JM; Nicholson, RI; Rushmere, NK; Walker, KJ; Wills, RJ1
Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC1
Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF; Walker, KJ1
Albrecht, M; Eiermann, W; Hilfrich, J; Jänicke, F; Jonat, W; Kaufmann, M; Kleeberg, U; Kreienberg, R; Schmid, H; Weitzel, HK1
Cantwell, BM; Carmichael, J; Dowsett, M; Harris, AL2
Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA1
Nicholson, RI; Walker, KJ1
Cantwell, BM; Dowsett, M; Harris, AL1
Cheson, BD1
Astone, A; Barone, C; Cassano, A; Garufi, C; Noviello, MR; Pietrantonio, F1
Barni, S; Cattaneo, G; Crispino, S; Lissoni, P; Tancini, G1
Blamey, RW; Dyas, J; Nicholson, RI; Plowman, PN; Turkes, A; Walker, KJ; Williams, M1
Blamey, RW; Nicholson, RI; Turkes, A; Walker, KJ; Williams, MR1
Nicholson, RI; Plowman, PN; Walker, KJ1
Cantwell, B; Dowsett, M; Harris, AL; Jeffcoate, SL; Lal, A1
Blamey, RW; Ellis, IO; Elston, CW; Nicholson, RI; Robertson, JF; Williamson, K1
Harvey, H; Lipton, A; Manni, A; Max, D; Santen, R1
Hesp, R; Katz, D; Matta, WH; Shaw, RW1
Evans, R; Hesp, R; Matta, WH; Shaw, RW1
Coombes, RC; Harland, SJ; Lister, TA; Malpas, JS; Powles, T; Waxman, JH; Wrigley, PF1
Fraser, HM; Howie, PW; Kerr-Wilson, RH; McNeilly, AS; Sandow, J; Shaw, RW1
Becher, R; Höffken, K; Miller, AA; Miller, B; Schmidt, CG1
Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW1

Reviews

4 review(s) available for buserelin and Menopause

ArticleYear
Role of antiprogestational therapy for meningiomas.
    Human reproduction (Oxford, England), 1994, Volume: 9 Suppl 1

    Topics: Buserelin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Male; Meningeal Neoplasms; Meningioma; Menopause; Mifepristone; Neoplasms, Hormone-Dependent; Pituitary-Adrenal System; Progesterone; Randomized Controlled Trials as Topic; Thyroid Gland

1994
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
    The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3

    Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause

1992
Gn-RH agonists in breast and gynaecologic cancer treatment.
    Journal of steroid biochemistry, 1989, Volume: 33, Issue:4B

    Topics: Animals; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Rats; Rats, Inbred Strains

1989
[Hormone therapy of metastatic breast carcinoma].
    Deutsche medizinische Wochenschrift (1946), 1985, Nov-22, Volume: 110, Issue:47

    Topics: Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Neoplasm Metastasis

1985

Trials

10 trial(s) available for buserelin and Menopause

ArticleYear
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.
    Breast cancer research and treatment, 1984, Volume: 4, Issue:3

    Topics: Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen

1984
Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Clinical obstetrics and gynecology, 1993, Volume: 36, Issue:3

    Topics: Administration, Intranasal; Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Hemoglobins; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Ultrasonography; Uterine Neoplasms

1993
Goserelin depot in the treatment of premenopausal advanced breast cancer.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5

    Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Menstruation; Middle Aged

1992
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study).
    European journal of gynaecological oncology, 1991, Volume: 12, Issue:6

    Topics: Adult; Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Life Tables; Luteinizing Hormone; Menopause; Middle Aged

1991
Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Fertility and sterility, 1991, Volume: 55, Issue:5

    Topics: Adult; Bone and Bones; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Random Allocation; Retrospective Studies; Uterine Neoplasms; Uterus

1991
Changes in thromboxane A2 generation and plasma lipid pattern in pseudomenopause induced by gonadotropin releasing hormone (GnRH) analogue buserelin.
    Prostaglandins, leukotrienes, and essential fatty acids, 1991, Volume: 43, Issue:3

    Topics: Adult; Blood Coagulation; Blood Platelets; Buserelin; Female; Gonadal Steroid Hormones; Humans; Leiomyoma; Lipids; Menopause; Middle Aged; Thromboxane A2; Uterine Neoplasms

1991
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
    British journal of cancer, 1990, Volume: 62, Issue:4

    Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy

1990
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Menopause; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Remission Induction

1989
Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.
    Clinical endocrinology, 1988, Volume: 29, Issue:1

    Topics: Adult; Bone and Bones; Buserelin; Endometriosis; Female; Femur; Humans; Lumbar Vertebrae; Menopause; Minerals; Ovary

1988
LHRH-agonist treatment in clinical and experimental human breast cancer.
    Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B

    Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen

1985

Other Studies

32 other study(ies) available for buserelin and Menopause

ArticleYear
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.
    Lancet (London, England), 1982, May-29, Volume: 1, Issue:8283

    Topics: Adult; Anovulation; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis

1982
Down-regulation of gonadotrophin secretion in postmenopausal women by a superactive LHRH analogue: lack of effect on menopausal flushing.
    British journal of obstetrics and gynaecology, 1982, Volume: 89, Issue:12

    Topics: Adult; Buserelin; Climacteric; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged

1982
Characteristics of urinary luteinizing hormone (LH) during the induction of LH surges of different magnitude in blood.
    Human reproduction (Oxford, England), 1995, Volume: 10, Issue:1

    Topics: Adult; Buserelin; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Ovulation Detection; Progesterone; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Time Factors

1995
Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen.
    Clinical and experimental obstetrics & gynecology, 1998, Volume: 25, Issue:3

    Topics: Adult; Buserelin; Chorionic Gonadotropin; Dydrogesterone; Embryo Transfer; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Menotropins; Oocyte Donation; Ovarian Follicle; Pregnancy; Primary Ovarian Insufficiency; Progesterone Congeners; Ultrasonography

1998
[Serum level of hCG-like substance in the patients of choriocarcinoma can be suppressed by Buserelin-administration].
    Nihon Sanka Fujinka Gakkai zasshi, 1992, Volume: 44, Issue:10

    Topics: Administration, Intranasal; Adult; Buserelin; Choriocarcinoma; Chorionic Gonadotropin; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Pregnancy; Remission Induction; Uterine Neoplasms

1992
Reversible menopause induced by the GnRH analogue buserelin: effects on lipoprotein metabolism.
    Acta endocrinologica, 1992, Volume: 127, Issue:2

    Topics: Adult; Apolipoproteins A; Apolipoproteins B; Buserelin; Coronary Disease; Endometriosis; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Radioimmunoassay; Risk Factors; Time Factors

1992
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
    The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8

    Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen

1992
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
    British journal of cancer, 1992, Volume: 65, Issue:5

    Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen

1992
Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
    Human reproduction (Oxford, England), 1991, Volume: 6, Issue:8

    Topics: Buserelin; Chorionic Gonadotropin; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menotropins; Ovariectomy; Prolactin

1991
[Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    La Clinica terapeutica, 1991, Feb-15, Volume: 136, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone; Thyroid Hormones

1991
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7

    Topics: Antibodies, Monoclonal; Breast Neoplasms; Buserelin; Cell Division; Female; Goserelin; Humans; Immunohistochemistry; Menopause; Predictive Value of Tests; Receptors, Estrogen; Tamoxifen

1991
Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
    Endocrinologia japonica, 1990, Volume: 37, Issue:6

    Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Buserelin; Estradiol; Female; Humans; Leiomyoma; Menopause; Middle Aged; Osteoporosis; Receptors, LHRH; Uterine Neoplasms; Uterus

1990
[Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nihon Sanka Fujinka Gakkai zasshi, 1990, Volume: 42, Issue:12

    Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Bone Density; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Uterine Neoplasms

1990
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:6

    Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms

1990
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.
    Annals of the New York Academy of Sciences, 1990, Volume: 595

    Topics: Breast Neoplasms; Buserelin; Estradiol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause; Polyunsaturated Alkamides; Tamoxifen

1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
    British journal of cancer, 1990, Volume: 62, Issue:5

    Topics: Adult; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Receptors, Estrogen; Survival Rate; Time Factors

1990
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
    British journal of cancer, 1989, Volume: 59, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged; Tamoxifen

1989
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
    British journal of cancer, 1989, Volume: 60, Issue:2

    Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen

1989
Endocrinology of Zoladex in postmenopausal women.
    Hormone research, 1989, Volume: 32 Suppl 1

    Topics: Androgens; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause

1989
Zoladex: therapeutic effects in postmenopausal breast cancer.
    Hormone research, 1989, Volume: 32 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged

1989
Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:6

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen

1989
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex.
    Cancer letters, 1989, Nov-30, Volume: 48, Issue:2

    Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause

1989
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer.
    Tumori, 1988, Jun-30, Volume: 74, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone

1988
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.
    Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B

    Topics: Adult; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Pituitary Gland; Progesterone; Receptors, Estrogen; Time Factors

1985
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
    The Journal of endocrinology, 1986, Volume: 111, Issue:2

    Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; Progesterone

1986
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
    British journal of cancer, 1986, Volume: 54, Issue:6

    Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction

1986
Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:4

    Topics: Aged; Aged, 80 and over; Androgens; Breast Neoplasms; Buserelin; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause; Middle Aged; Ovary

1988
Effect of LHRH agonist, Zoladex, on ovarian histology.
    The British journal of surgery, 1988, Volume: 75, Issue:6

    Topics: Breast Neoplasms; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Menopause; Ovariectomy; Ovary

1988
Treatment of breast cancer with gonadotropin-releasing hormone.
    Endocrine reviews, 1986, Volume: 7, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Tamoxifen

1986
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
    British medical journal (Clinical research ed.), 1987, Jun-13, Volume: 294, Issue:6586

    Topics: Absorptiometry, Photon; Adult; Bone and Bones; Buserelin; Female; Femur; Humans; Hypogonadism; Lumbar Vertebrae; Menopause; Tomography, X-Ray Computed

1987
The treatment of postmenopausal women with advanced breast cancer with buserelin.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2

    Topics: Adenocarcinoma; Aged; Breast Neoplasms; Buserelin; Female; Gonadotropins, Pituitary; Humans; Hypophysectomy, Chemical; Lymphatic Metastasis; Menopause; Middle Aged; Time Factors

1985
Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women.
    Maturitas, 1985, Volume: 7, Issue:2

    Topics: Administration, Intranasal; Adult; Buserelin; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menopause; Middle Aged

1985
chemdatabank.com